[Federal Register Volume 86, Number 22 (Thursday, February 4, 2021)]
[Notices]
[Page 8204]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-02289]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; SEP-2: Research Answers to NCI Provocative Questions.
    Date: February 23, 2021.
    Time: 12:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W104, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: David G. Ransom, Ph.D., Chief, Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W104, Rockville, Maryland 20850, 240-276-6351, 
<a href="/cdn-cgi/l/email-protection#fa9e9b8c939ed4889b94899597ba949392d49d958c"><span class="__cf_email__" data-cfemail="4a2e2b3c232e64382b243925270a242322642d253c">[email protected]</span></a>.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI SPORE (P50) Review V.
    Date: February 25-26, 2021.
    Time: 10:00 a.m. to 7:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W120, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: Majed M. Hamawy, Ph.D., Scientific Review 
Officer, Research Programs Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W120, Rockville, Maryland 20850, 240-276-6457, 
<a href="/cdn-cgi/l/email-protection#f79a9fc6c7c681b7999e9fd9909881"><span class="__cf_email__" data-cfemail="2b46431a1b1a5d6b454243054c445d">[email protected]</span></a>.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Visualization Methods and Tools Development for Enhancing 
Cancer Moonshot Data (R33).
    Date: March 10, 2021.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W108, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: Clifford W. Schweinfest, Ph.D., Scientific 
Review Officer, Special Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W108, Rockville, Maryland 20850, 240-276-6343, 
<a href="/cdn-cgi/l/email-protection#2a5949425d4f43444c4f595e495d6a474b434604444342044d455c"><span class="__cf_email__" data-cfemail="0d7e6e657a6864636b687e796e7a4d606c646123636465236a627b">[email protected]</span></a>.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; SEP-7: NCI Clinical and Translational R21 and Omnibus R03 
Review.
    Date: March 16-17, 2021.
    Time: 9:00 a.m. to 5:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W104, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: David G. Ransom, Ph.D., Chief, Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W104, Rockville, Maryland 20850, 240-276-6351, 
<a href="/cdn-cgi/l/email-protection#aacecbdcc3ce84d8cbc4d9c5c7eac4c3c284cdc5dc"><span class="__cf_email__" data-cfemail="a3c7c2d5cac78dd1c2cdd0cccee3cdcacb8dc4ccd5">[email protected]</span></a>.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; 3D Technologies to Accelerate HTAN.
    Date: March 19, 2021.
    Time: 9:30 a.m. to 1:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W556, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: Kamal Datta, M.D., Scientific Review Officer, 
Program Coordination and Referral Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W556, Rockville, Maryland 20850, 240-276-6526, 
<a href="/cdn-cgi/l/email-protection#96fdf7fbf7fab8f2f7e2e2f7d6f8fffeb8f1f9e0"><span class="__cf_email__" data-cfemail="95fef4f8f4f9bbf1f4e1e1f4d5fbfcfdbbf2fae3">[email protected]</span></a>.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; R01(IARC) Conference Grant Review.
    Date: April 6, 2021.
    Time: 1:30 p.m. to 4:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W552, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: Jeanette Irene Marketon, Ph.D., Scientific 
Review Officer, Program Coordination and Referral Branch, Division 
of Extramural Activities, National Cancer Institute, NIH, 9609 
Medical Center Drive, Room 7W552, Rockville, Maryland 20850, 240-
276-6780, <a href="/cdn-cgi/l/email-protection#761c13171813020213581b17041d1302191836181f1e58111900"><span class="__cf_email__" data-cfemail="c2a8a7a3aca7b6b6a7ecafa3b0a9a7b6adac82acabaaeca5adb4">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: January 26, 2021.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-02289 Filed 2-3-21; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>